ENDRA Life Sciences (NDRA) Non Operating Income (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Non Operating Income of $862315.0 for Q1 2026, up 99.17% YoY from $432952.0 in Q1 2025, and up 164.17% sequentially from -$1.3 million in Q4 2025.
ENDRA Life Sciences (NDRA) Non Operating Income (2016 - 2026) Analysis & Trends
ENDRA Life Sciences has disclosed Non Operating Income across 11 years of filings, most recently posting $862315.0 for Q1 2026.
- In Q1 2026, Non Operating Income rose 99.17% year-over-year to $862315.0; the TTM figure through Mar 2026 stood at -$693658.0 (down 154.2% YoY), while the FY2025 annual figure was -$1.3 million, down 2046.53% from the prior year.
- Non Operating Income grew to $862315.0 in Q1 2026, from -$1.3 million in the prior quarter.
- Over the last five years, Non Operating Income for NDRA reached as high as $862315.0 in Q1 2026 and fell as low as -$1.3 million in Q4 2025.
- The 5-year median for Non Operating Income is $4841.0 (2024), against an average of $33900.1.
- Annual changes were most pronounced in 2023 — Non Operating Income tumbled 2043.41% — and 2025, when it soared 8843.44%.
- A 5-year view of Non Operating Income shows it stood at $23785.0 in 2022, then plunged by 2043.41% to -$462241.0 in 2023, then surged by 268.66% to $779635.0 in 2024, then plunged by 272.36% to -$1.3 million in 2025, then surged by 164.17% to $862315.0 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $862315.0, -$1.3 million, and -$225256.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 1.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -9.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -73.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 9.60 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 21.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -4.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -52.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 7.33 Mn |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - | 862,315.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 862,315.00 |
| Dec 31, 2025 | -1.34 Mn |
| Sep 30, 2025 | -225,256.00 |
| Jun 30, 2025 | 13,066.00 |
| Mar 31, 2025 | 432,952.00 |
| Dec 31, 2024 | 779,635.00 |
| Sep 30, 2024 | 65,528.00 |
| Jun 30, 2024 | 1,700.00 |
| Mar 31, 2024 | 4,841.00 |
| Dec 31, 2023 | -462,241.00 |
| Sep 30, 2023 | 28,226.00 |
| Jun 30, 2023 | 437,433.00 |
| Mar 31, 2023 | 3,418.00 |
| Dec 31, 2022 | 23,785.00 |
| Sep 30, 2022 | -23,011.00 |
| Jun 30, 2022 | -19,374.00 |
| Mar 31, 2022 | -2,933.00 |
| Dec 31, 2021 | -33,087.00 |
| Sep 30, 2021 | -7,507.00 |
| Jun 30, 2021 | 1,086.00 |